Global Aflibercept Biosimilars Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Aflibercept Biosimilars Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Aflibercept Biosimilars by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Aflibercept Biosimilars by Country/Region, 2017, 2022 & 2028

2.2 Aflibercept Biosimilars Segment by Type

2.2.1 Intravitreal Injection

2.2.2 Intravenous Injection

2.3 Aflibercept Biosimilars Sales by Type

2.3.1 Global Aflibercept Biosimilars Sales Market Share by Type (2017-2022)

2.3.2 Global Aflibercept Biosimilars Revenue and Market Share by Type (2017-2022)

2.3.3 Global Aflibercept Biosimilars Sale Price by Type (2017-2022)

2.4 Aflibercept Biosimilars Segment by Application

2.4.1 Wet Macular Degeneration

2.4.2 Metastatic Colorectal Cancer

2.5 Aflibercept Biosimilars Sales by Application

2.5.1 Global Aflibercept Biosimilars Sale Market Share by Application (2017-2022)

2.5.2 Global Aflibercept Biosimilars Revenue and Market Share by Application (2017-2022)

2.5.3 Global Aflibercept Biosimilars Sale Price by Application (2017-2022)

3 Global Aflibercept Biosimilars by Company

3.1 Global Aflibercept Biosimilars Breakdown Data by Company

3.1.1 Global Aflibercept Biosimilars Annual Sales by Company (2020-2022)

3.1.2 Global Aflibercept Biosimilars Sales Market Share by Company (2020-2022)

3.2 Global Aflibercept Biosimilars Annual Revenue by Company (2020-2022)

3.2.1 Global Aflibercept Biosimilars Revenue by Company (2020-2022)

3.2.2 Global Aflibercept Biosimilars Revenue Market Share by Company (2020-2022)

3.3 Global Aflibercept Biosimilars Sale Price by Company

3.4 Key Manufacturers Aflibercept Biosimilars Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Aflibercept Biosimilars Product Location Distribution

3.4.2 Players Aflibercept Biosimilars Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Aflibercept Biosimilars by Geographic Region

4.1 World Historic Aflibercept Biosimilars Market Size by Geographic Region (2017-2022)

4.1.1 Global Aflibercept Biosimilars Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Aflibercept Biosimilars Annual Revenue by Geographic Region

4.2 World Historic Aflibercept Biosimilars Market Size by Country/Region (2017-2022)

4.2.1 Global Aflibercept Biosimilars Annual Sales by Country/Region (2017-2022)

4.2.2 Global Aflibercept Biosimilars Annual Revenue by Country/Region

4.3 Americas Aflibercept Biosimilars Sales Growth

4.4 APAC Aflibercept Biosimilars Sales Growth

4.5 Europe Aflibercept Biosimilars Sales Growth

4.6 Middle East & Africa Aflibercept Biosimilars Sales Growth

5 Americas

5.1 Americas Aflibercept Biosimilars Sales by Country

5.1.1 Americas Aflibercept Biosimilars Sales by Country (2017-2022)

5.1.2 Americas Aflibercept Biosimilars Revenue by Country (2017-2022)

5.2 Americas Aflibercept Biosimilars Sales by Type

5.3 Americas Aflibercept Biosimilars Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Aflibercept Biosimilars Sales by Region

6.1.1 APAC Aflibercept Biosimilars Sales by Region (2017-2022)

6.1.2 APAC Aflibercept Biosimilars Revenue by Region (2017-2022)

6.2 APAC Aflibercept Biosimilars Sales by Type

6.3 APAC Aflibercept Biosimilars Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Aflibercept Biosimilars by Country

7.1.1 Europe Aflibercept Biosimilars Sales by Country (2017-2022)

7.1.2 Europe Aflibercept Biosimilars Revenue by Country (2017-2022)

7.2 Europe Aflibercept Biosimilars Sales by Type

7.3 Europe Aflibercept Biosimilars Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Aflibercept Biosimilars by Country

8.1.1 Middle East & Africa Aflibercept Biosimilars Sales by Country (2017-2022)

8.1.2 Middle East & Africa Aflibercept Biosimilars Revenue by Country (2017-2022)

8.2 Middle East & Africa Aflibercept Biosimilars Sales by Type

8.3 Middle East & Africa Aflibercept Biosimilars Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Aflibercept Biosimilars

10.3 Manufacturing Process Analysis of Aflibercept Biosimilars

10.4 Industry Chain Structure of Aflibercept Biosimilars

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Aflibercept Biosimilars Distributors

11.3 Aflibercept Biosimilars Customer

12 World Forecast Review for Aflibercept Biosimilars by Geographic Region

12.1 Global Aflibercept Biosimilars Market Size Forecast by Region

12.1.1 Global Aflibercept Biosimilars Forecast by Region (2023-2028)

12.1.2 Global Aflibercept Biosimilars Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Aflibercept Biosimilars Forecast by Type

12.7 Global Aflibercept Biosimilars Forecast by Application

13 Key Players Analysis

13.1 Regeneron

13.1.1 Regeneron Company Information

13.1.2 Regeneron Aflibercept Biosimilars Product Offered

13.1.3 Regeneron Aflibercept Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Regeneron Main Business Overview

13.1.5 Regeneron Latest Developments

13.2 Sanofi

13.2.1 Sanofi Company Information

13.2.2 Sanofi Aflibercept Biosimilars Product Offered

13.2.3 Sanofi Aflibercept Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Sanofi Main Business Overview

13.2.5 Sanofi Latest Developments

13.3 Novartis

13.3.1 Novartis Company Information

13.3.2 Novartis Aflibercept Biosimilars Product Offered

13.3.3 Novartis Aflibercept Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Novartis Main Business Overview

13.3.5 Novartis Latest Developments

13.4 Genentech

13.4.1 Genentech Company Information

13.4.2 Genentech Aflibercept Biosimilars Product Offered

13.4.3 Genentech Aflibercept Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Genentech Main Business Overview

13.4.5 Genentech Latest Developments

13.5 Roche

13.5.1 Roche Company Information

13.5.2 Roche Aflibercept Biosimilars Product Offered

13.5.3 Roche Aflibercept Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Roche Main Business Overview

13.5.5 Roche Latest Developments

13.6 Pfizer

13.6.1 Pfizer Company Information

13.6.2 Pfizer Aflibercept Biosimilars Product Offered

13.6.3 Pfizer Aflibercept Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Pfizer Main Business Overview

13.6.5 Pfizer Latest Developments

13.7 Sartorius

13.7.1 Sartorius Company Information

13.7.2 Sartorius Aflibercept Biosimilars Product Offered

13.7.3 Sartorius Aflibercept Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Sartorius Main Business Overview

13.7.5 Sartorius Latest Developments

13.8 Eli Lilly

13.8.1 Eli Lilly Company Information

13.8.2 Eli Lilly Aflibercept Biosimilars Product Offered

13.8.3 Eli Lilly Aflibercept Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Eli Lilly Main Business Overview

13.8.5 Eli Lilly Latest Developments

13.9 Bayer

13.9.1 Bayer Company Information

13.9.2 Bayer Aflibercept Biosimilars Product Offered

13.9.3 Bayer Aflibercept Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Bayer Main Business Overview

13.9.5 Bayer Latest Developments

13.10 Amgen

13.10.1 Amgen Company Information

13.10.2 Amgen Aflibercept Biosimilars Product Offered

13.10.3 Amgen Aflibercept Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Amgen Main Business Overview

13.10.5 Amgen Latest Developments

13.11 PlantForm

13.11.1 PlantForm Company Information

13.11.2 PlantForm Aflibercept Biosimilars Product Offered

13.11.3 PlantForm Aflibercept Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 PlantForm Main Business Overview

13.11.5 PlantForm Latest Developments

13.12 PharmaPraxis

13.12.1 PharmaPraxis Company Information

13.12.2 PharmaPraxis Aflibercept Biosimilars Product Offered

13.12.3 PharmaPraxis Aflibercept Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 PharmaPraxis Main Business Overview

13.12.5 PharmaPraxis Latest Developments

13.13 Samsung Bioepis

13.13.1 Samsung Bioepis Company Information

13.13.2 Samsung Bioepis Aflibercept Biosimilars Product Offered

13.13.3 Samsung Bioepis Aflibercept Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Samsung Bioepis Main Business Overview

13.13.5 Samsung Bioepis Latest Developments

13.14 Centus

13.14.1 Centus Company Information

13.14.2 Centus Aflibercept Biosimilars Product Offered

13.14.3 Centus Aflibercept Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Centus Main Business Overview

13.14.5 Centus Latest Developments

13.15 Cadila Pharmaceuticals

13.15.1 Cadila Pharmaceuticals Company Information

13.15.2 Cadila Pharmaceuticals Aflibercept Biosimilars Product Offered

13.15.3 Cadila Pharmaceuticals Aflibercept Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Cadila Pharmaceuticals Main Business Overview

13.15.5 Cadila Pharmaceuticals Latest Developments

13.16 Dr Reddy's

13.16.1 Dr Reddy's Company Information

13.16.2 Dr Reddy's Aflibercept Biosimilars Product Offered

13.16.3 Dr Reddy's Aflibercept Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Dr Reddy's Main Business Overview

13.16.5 Dr Reddy's Latest Developments

13.17 Aurobindo Pharma

13.17.1 Aurobindo Pharma Company Information

13.17.2 Aurobindo Pharma Aflibercept Biosimilars Product Offered

13.17.3 Aurobindo Pharma Aflibercept Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Aurobindo Pharma Main Business Overview

13.17.5 Aurobindo Pharma Latest Developments

13.18 Biocad

13.18.1 Biocad Company Information

13.18.2 Biocad Aflibercept Biosimilars Product Offered

13.18.3 Biocad Aflibercept Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Biocad Main Business Overview

13.18.5 Biocad Latest Developments

13.19 MAbxience

13.19.1 MAbxience Company Information

13.19.2 MAbxience Aflibercept Biosimilars Product Offered

13.19.3 MAbxience Aflibercept Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 MAbxience Main Business Overview

13.19.5 MAbxience Latest Developments

13.20 Hetero

13.20.1 Hetero Company Information

13.20.2 Hetero Aflibercept Biosimilars Product Offered

13.20.3 Hetero Aflibercept Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.20.4 Hetero Main Business Overview

13.20.5 Hetero Latest Developments

13.21 Biocon

13.21.1 Biocon Company Information

13.21.2 Biocon Aflibercept Biosimilars Product Offered

13.21.3 Biocon Aflibercept Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.21.4 Biocon Main Business Overview

13.21.5 Biocon Latest Developments

13.22 Kirin Biologics

13.22.1 Kirin Biologics Company Information

13.22.2 Kirin Biologics Aflibercept Biosimilars Product Offered

13.22.3 Kirin Biologics Aflibercept Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.22.4 Kirin Biologics Main Business Overview

13.22.5 Kirin Biologics Latest Developments

13.23 Mylan

13.23.1 Mylan Company Information

13.23.2 Mylan Aflibercept Biosimilars Product Offered

13.23.3 Mylan Aflibercept Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.23.4 Mylan Main Business Overview

13.23.5 Mylan Latest Developments

13.24 BeiGene

13.24.1 BeiGene Company Information

13.24.2 BeiGene Aflibercept Biosimilars Product Offered

13.24.3 BeiGene Aflibercept Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.24.4 BeiGene Main Business Overview

13.24.5 BeiGene Latest Developments

13.25 Innovent

13.25.1 Innovent Company Information

13.25.2 Innovent Aflibercept Biosimilars Product Offered

13.25.3 Innovent Aflibercept Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.25.4 Innovent Main Business Overview

13.25.5 Innovent Latest Developments

13.26 Qilu Pharmaceutical

13.26.1 Qilu Pharmaceutical Company Information

13.26.2 Qilu Pharmaceutical Aflibercept Biosimilars Product Offered

13.26.3 Qilu Pharmaceutical Aflibercept Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.26.4 Qilu Pharmaceutical Main Business Overview

13.26.5 Qilu Pharmaceutical Latest Developments

13.27 Hengrui Pharmaceuticals

13.27.1 Hengrui Pharmaceuticals Company Information

13.27.2 Hengrui Pharmaceuticals Aflibercept Biosimilars Product Offered

13.27.3 Hengrui Pharmaceuticals Aflibercept Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.27.4 Hengrui Pharmaceuticals Main Business Overview

13.27.5 Hengrui Pharmaceuticals Latest Developments

13.28 Hisun Pharmaceutical

13.28.1 Hisun Pharmaceutical Company Information

13.28.2 Hisun Pharmaceutical Aflibercept Biosimilars Product Offered

13.28.3 Hisun Pharmaceutical Aflibercept Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.28.4 Hisun Pharmaceutical Main Business Overview

13.28.5 Hisun Pharmaceutical Latest Developments

13.29 TOT BIOPHARM

13.29.1 TOT BIOPHARM Company Information

13.29.2 TOT BIOPHARM Aflibercept Biosimilars Product Offered

13.29.3 TOT BIOPHARM Aflibercept Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)

13.29.4 TOT BIOPHARM Main Business Overview

13.29.5 TOT BIOPHARM Latest Developments

14 Research Findings and Conclusion

Table 1. Aflibercept Biosimilars Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Aflibercept Biosimilars Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Intravitreal Injection

Table 4. Major Players of Intravenous Injection

Table 5. Global Aflibercept Biosimilars Sales by Type (2017-2022) & (K Units)

Table 6. Global Aflibercept Biosimilars Sales Market Share by Type (2017-2022)

Table 7. Global Aflibercept Biosimilars Revenue by Type (2017-2022) & ($ million)

Table 8. Global Aflibercept Biosimilars Revenue Market Share by Type (2017-2022)

Table 9. Global Aflibercept Biosimilars Sale Price by Type (2017-2022) & (K USD/Unit)

Table 10. Global Aflibercept Biosimilars Sales by Application (2017-2022) & (K Units)

Table 11. Global Aflibercept Biosimilars Sales Market Share by Application (2017-2022)

Table 12. Global Aflibercept Biosimilars Revenue by Application (2017-2022)

Table 13. Global Aflibercept Biosimilars Revenue Market Share by Application (2017-2022)

Table 14. Global Aflibercept Biosimilars Sale Price by Application (2017-2022) & (K USD/Unit)

Table 15. Global Aflibercept Biosimilars Sales by Company (2020-2022) & (K Units)

Table 16. Global Aflibercept Biosimilars Sales Market Share by Company (2020-2022)

Table 17. Global Aflibercept Biosimilars Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Aflibercept Biosimilars Revenue Market Share by Company (2020-2022)

Table 19. Global Aflibercept Biosimilars Sale Price by Company (2020-2022) & (K USD/Unit)

Table 20. Key Manufacturers Aflibercept Biosimilars Producing Area Distribution and Sales Area

Table 21. Players Aflibercept Biosimilars Products Offered

Table 22. Aflibercept Biosimilars Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Aflibercept Biosimilars Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Aflibercept Biosimilars Sales Market Share Geographic Region (2017-2022)

Table 27. Global Aflibercept Biosimilars Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Aflibercept Biosimilars Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Aflibercept Biosimilars Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Aflibercept Biosimilars Sales Market Share by Country/Region (2017-2022)

Table 31. Global Aflibercept Biosimilars Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Aflibercept Biosimilars Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Aflibercept Biosimilars Sales by Country (2017-2022) & (K Units)

Table 34. Americas Aflibercept Biosimilars Sales Market Share by Country (2017-2022)

Table 35. Americas Aflibercept Biosimilars Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Aflibercept Biosimilars Revenue Market Share by Country (2017-2022)

Table 37. Americas Aflibercept Biosimilars Sales by Type (2017-2022) & (K Units)

Table 38. Americas Aflibercept Biosimilars Sales Market Share by Type (2017-2022)

Table 39. Americas Aflibercept Biosimilars Sales by Application (2017-2022) & (K Units)

Table 40. Americas Aflibercept Biosimilars Sales Market Share by Application (2017-2022)

Table 41. APAC Aflibercept Biosimilars Sales by Region (2017-2022) & (K Units)

Table 42. APAC Aflibercept Biosimilars Sales Market Share by Region (2017-2022)

Table 43. APAC Aflibercept Biosimilars Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Aflibercept Biosimilars Revenue Market Share by Region (2017-2022)

Table 45. APAC Aflibercept Biosimilars Sales by Type (2017-2022) & (K Units)

Table 46. APAC Aflibercept Biosimilars Sales Market Share by Type (2017-2022)

Table 47. APAC Aflibercept Biosimilars Sales by Application (2017-2022) & (K Units)

Table 48. APAC Aflibercept Biosimilars Sales Market Share by Application (2017-2022)

Table 49. Europe Aflibercept Biosimilars Sales by Country (2017-2022) & (K Units)

Table 50. Europe Aflibercept Biosimilars Sales Market Share by Country (2017-2022)

Table 51. Europe Aflibercept Biosimilars Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Aflibercept Biosimilars Revenue Market Share by Country (2017-2022)

Table 53. Europe Aflibercept Biosimilars Sales by Type (2017-2022) & (K Units)

Table 54. Europe Aflibercept Biosimilars Sales Market Share by Type (2017-2022)

Table 55. Europe Aflibercept Biosimilars Sales by Application (2017-2022) & (K Units)

Table 56. Europe Aflibercept Biosimilars Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Aflibercept Biosimilars Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Aflibercept Biosimilars Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Aflibercept Biosimilars Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Aflibercept Biosimilars Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Aflibercept Biosimilars Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Aflibercept Biosimilars Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Aflibercept Biosimilars Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Aflibercept Biosimilars Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Aflibercept Biosimilars

Table 66. Key Market Challenges & Risks of Aflibercept Biosimilars

Table 67. Key Industry Trends of Aflibercept Biosimilars

Table 68. Aflibercept Biosimilars Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Aflibercept Biosimilars Distributors List

Table 71. Aflibercept Biosimilars Customer List

Table 72. Global Aflibercept Biosimilars Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Aflibercept Biosimilars Sales Market Forecast by Region

Table 74. Global Aflibercept Biosimilars Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Aflibercept Biosimilars Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Aflibercept Biosimilars Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Aflibercept Biosimilars Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Aflibercept Biosimilars Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Aflibercept Biosimilars Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Aflibercept Biosimilars Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Aflibercept Biosimilars Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Aflibercept Biosimilars Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Aflibercept Biosimilars Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Aflibercept Biosimilars Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Aflibercept Biosimilars Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Aflibercept Biosimilars Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Aflibercept Biosimilars Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Aflibercept Biosimilars Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Aflibercept Biosimilars Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Aflibercept Biosimilars Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Aflibercept Biosimilars Revenue Market Share Forecast by Application (2023-2028)

Table 92. Regeneron Basic Information, Aflibercept Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 93. Regeneron Aflibercept Biosimilars Product Offered

Table 94. Regeneron Aflibercept Biosimilars Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 95. Regeneron Main Business

Table 96. Regeneron Latest Developments

Table 97. Sanofi Basic Information, Aflibercept Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 98. Sanofi Aflibercept Biosimilars Product Offered

Table 99. Sanofi Aflibercept Biosimilars Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 100. Sanofi Main Business

Table 101. Sanofi Latest Developments

Table 102. Novartis Basic Information, Aflibercept Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 103. Novartis Aflibercept Biosimilars Product Offered

Table 104. Novartis Aflibercept Biosimilars Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 105. Novartis Main Business

Table 106. Novartis Latest Developments

Table 107. Genentech Basic Information, Aflibercept Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 108. Genentech Aflibercept Biosimilars Product Offered

Table 109. Genentech Aflibercept Biosimilars Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 110. Genentech Main Business

Table 111. Genentech Latest Developments

Table 112. Roche Basic Information, Aflibercept Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 113. Roche Aflibercept Biosimilars Product Offered

Table 114. Roche Aflibercept Biosimilars Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 115. Roche Main Business

Table 116. Roche Latest Developments

Table 117. Pfizer Basic Information, Aflibercept Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 118. Pfizer Aflibercept Biosimilars Product Offered

Table 119. Pfizer Aflibercept Biosimilars Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 120. Pfizer Main Business

Table 121. Pfizer Latest Developments

Table 122. Sartorius Basic Information, Aflibercept Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 123. Sartorius Aflibercept Biosimilars Product Offered

Table 124. Sartorius Aflibercept Biosimilars Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 125. Sartorius Main Business

Table 126. Sartorius Latest Developments

Table 127. Eli Lilly Basic Information, Aflibercept Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 128. Eli Lilly Aflibercept Biosimilars Product Offered

Table 129. Eli Lilly Aflibercept Biosimilars Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 130. Eli Lilly Main Business

Table 131. Eli Lilly Latest Developments

Table 132. Bayer Basic Information, Aflibercept Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 133. Bayer Aflibercept Biosimilars Product Offered

Table 134. Bayer Aflibercept Biosimilars Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 135. Bayer Main Business

Table 136. Bayer Latest Developments

Table 137. Amgen Basic Information, Aflibercept Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 138. Amgen Aflibercept Biosimilars Product Offered

Table 139. Amgen Aflibercept Biosimilars Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 140. Amgen Main Business

Table 141. Amgen Latest Developments

Table 142. PlantForm Basic Information, Aflibercept Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 143. PlantForm Aflibercept Biosimilars Product Offered

Table 144. PlantForm Aflibercept Biosimilars Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 145. PlantForm Main Business

Table 146. PlantForm Latest Developments

Table 147. PharmaPraxis Basic Information, Aflibercept Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 148. PharmaPraxis Aflibercept Biosimilars Product Offered

Table 149. PharmaPraxis Aflibercept Biosimilars Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 150. PharmaPraxis Main Business

Table 151. PharmaPraxis Latest Developments

Table 152. Samsung Bioepis Basic Information, Aflibercept Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 153. Samsung Bioepis Aflibercept Biosimilars Product Offered

Table 154. Samsung Bioepis Aflibercept Biosimilars Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 155. Samsung Bioepis Main Business

Table 156. Samsung Bioepis Latest Developments

Table 157. Centus Basic Information, Aflibercept Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 158. Centus Aflibercept Biosimilars Product Offered

Table 159. Centus Aflibercept Biosimilars Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 160. Centus Main Business

Table 161. Centus Latest Developments

Table 162. Cadila Pharmaceuticals Basic Information, Aflibercept Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 163. Cadila Pharmaceuticals Aflibercept Biosimilars Product Offered

Table 164. Cadila Pharmaceuticals Aflibercept Biosimilars Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 165. Cadila Pharmaceuticals Main Business

Table 166. Cadila Pharmaceuticals Latest Developments

Table 167. Dr Reddy's Basic Information, Aflibercept Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 168. Dr Reddy's Aflibercept Biosimilars Product Offered

Table 169. Dr Reddy's Aflibercept Biosimilars Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 170. Dr Reddy's Main Business

Table 171. Dr Reddy's Latest Developments

Table 172. Aurobindo Pharma Basic Information, Aflibercept Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 173. Aurobindo Pharma Aflibercept Biosimilars Product Offered

Table 174. Aurobindo Pharma Aflibercept Biosimilars Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 175. Aurobindo Pharma Main Business

Table 176. Aurobindo Pharma Latest Developments

Table 177. Biocad Basic Information, Aflibercept Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 178. Biocad Aflibercept Biosimilars Product Offered

Table 179. Biocad Aflibercept Biosimilars Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 180. Biocad Main Business

Table 181. Biocad Latest Developments

Table 182. MAbxience Basic Information, Aflibercept Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 183. MAbxience Aflibercept Biosimilars Product Offered

Table 184. MAbxience Aflibercept Biosimilars Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 185. MAbxience Main Business

Table 186. MAbxience Latest Developments

Table 187. Hetero Basic Information, Aflibercept Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 188. Hetero Aflibercept Biosimilars Product Offered

Table 189. Hetero Aflibercept Biosimilars Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 190. Hetero Main Business

Table 191. Hetero Latest Developments

Table 192. Biocon Basic Information, Aflibercept Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 193. Biocon Aflibercept Biosimilars Product Offered

Table 194. Biocon Aflibercept Biosimilars Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 195. Biocon Main Business

Table 196. Biocon Latest Developments

Table 197. Kirin Biologics Basic Information, Aflibercept Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 198. Kirin Biologics Aflibercept Biosimilars Product Offered

Table 199. Kirin Biologics Aflibercept Biosimilars Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 200. Kirin Biologics Main Business

Table 201. Kirin Biologics Latest Developments

Table 202. Mylan Basic Information, Aflibercept Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 203. Mylan Aflibercept Biosimilars Product Offered

Table 204. Mylan Aflibercept Biosimilars Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 205. Mylan Main Business

Table 206. Mylan Latest Developments

Table 207. BeiGene Basic Information, Aflibercept Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 208. BeiGene Aflibercept Biosimilars Product Offered

Table 209. BeiGene Aflibercept Biosimilars Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 210. BeiGene Main Business

Table 211. BeiGene Latest Developments

Table 212. Innovent Basic Information, Aflibercept Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 213. Innovent Aflibercept Biosimilars Product Offered

Table 214. Innovent Aflibercept Biosimilars Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 215. Innovent Main Business

Table 216. Innovent Latest Developments

Table 217. Qilu Pharmaceutical Basic Information, Aflibercept Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 218. Qilu Pharmaceutical Aflibercept Biosimilars Product Offered

Table 219. Qilu Pharmaceutical Aflibercept Biosimilars Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 220. Qilu Pharmaceutical Main Business

Table 221. Qilu Pharmaceutical Latest Developments

Table 222. Hengrui Pharmaceuticals Basic Information, Aflibercept Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 223. Hengrui Pharmaceuticals Aflibercept Biosimilars Product Offered

Table 224. Hengrui Pharmaceuticals Aflibercept Biosimilars Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 225. Hengrui Pharmaceuticals Main Business

Table 226. Hengrui Pharmaceuticals Latest Developments

Table 227. Hisun Pharmaceutical Basic Information, Aflibercept Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 228. Hisun Pharmaceutical Aflibercept Biosimilars Product Offered

Table 229. Hisun Pharmaceutical Aflibercept Biosimilars Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 230. Hisun Pharmaceutical Main Business

Table 231. Hisun Pharmaceutical Latest Developments

Table 232. TOT BIOPHARM Basic Information, Aflibercept Biosimilars Manufacturing Base, Sales Area and Its Competitors

Table 233. TOT BIOPHARM Aflibercept Biosimilars Product Offered

Table 234. TOT BIOPHARM Aflibercept Biosimilars Sales (K Units), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2020-2022)

Table 235. TOT BIOPHARM Main Business

Table 236. TOT BIOPHARM Latest Developments

List of Figures

Figure 1. Picture of Aflibercept Biosimilars

Figure 2. Aflibercept Biosimilars Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Aflibercept Biosimilars Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Aflibercept Biosimilars Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Aflibercept Biosimilars Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Intravitreal Injection

Figure 10. Product Picture of Intravenous Injection

Figure 11. Global Aflibercept Biosimilars Sales Market Share by Type in 2021

Figure 12. Global Aflibercept Biosimilars Revenue Market Share by Type (2017-2022)

Figure 13. Aflibercept Biosimilars Consumed in Wet Macular Degeneration

Figure 14. Global Aflibercept Biosimilars Market: Wet Macular Degeneration (2017-2022) & (K Units)

Figure 15. Aflibercept Biosimilars Consumed in Metastatic Colorectal Cancer

Figure 16. Global Aflibercept Biosimilars Market: Metastatic Colorectal Cancer (2017-2022) & (K Units)

Figure 17. Global Aflibercept Biosimilars Sales Market Share by Application (2017-2022)

Figure 18. Global Aflibercept Biosimilars Revenue Market Share by Application in 2021

Figure 19. Aflibercept Biosimilars Revenue Market by Company in 2021 ($ Million)

Figure 20. Global Aflibercept Biosimilars Revenue Market Share by Company in 2021

Figure 21. Global Aflibercept Biosimilars Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global Aflibercept Biosimilars Revenue Market Share by Geographic Region in 2021

Figure 23. Global Aflibercept Biosimilars Sales Market Share by Region (2017-2022)

Figure 24. Global Aflibercept Biosimilars Revenue Market Share by Country/Region in 2021

Figure 25. Americas Aflibercept Biosimilars Sales 2017-2022 (K Units)

Figure 26. Americas Aflibercept Biosimilars Revenue 2017-2022 ($ Millions)

Figure 27. APAC Aflibercept Biosimilars Sales 2017-2022 (K Units)

Figure 28. APAC Aflibercept Biosimilars Revenue 2017-2022 ($ Millions)

Figure 29. Europe Aflibercept Biosimilars Sales 2017-2022 (K Units)

Figure 30. Europe Aflibercept Biosimilars Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa Aflibercept Biosimilars Sales 2017-2022 (K Units)

Figure 32. Middle East & Africa Aflibercept Biosimilars Revenue 2017-2022 ($ Millions)

Figure 33. Americas Aflibercept Biosimilars Sales Market Share by Country in 2021

Figure 34. Americas Aflibercept Biosimilars Revenue Market Share by Country in 2021

Figure 35. United States Aflibercept Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada Aflibercept Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico Aflibercept Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil Aflibercept Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC Aflibercept Biosimilars Sales Market Share by Region in 2021

Figure 40. APAC Aflibercept Biosimilars Revenue Market Share by Regions in 2021

Figure 41. China Aflibercept Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan Aflibercept Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea Aflibercept Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia Aflibercept Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 45. India Aflibercept Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia Aflibercept Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe Aflibercept Biosimilars Sales Market Share by Country in 2021

Figure 48. Europe Aflibercept Biosimilars Revenue Market Share by Country in 2021

Figure 49. Germany Aflibercept Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 50. France Aflibercept Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK Aflibercept Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy Aflibercept Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia Aflibercept Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa Aflibercept Biosimilars Sales Market Share by Country in 2021

Figure 55. Middle East & Africa Aflibercept Biosimilars Revenue Market Share by Country in 2021

Figure 56. Egypt Aflibercept Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa Aflibercept Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel Aflibercept Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey Aflibercept Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Aflibercept Biosimilars Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of Aflibercept Biosimilars in 2021

Figure 62. Manufacturing Process Analysis of Aflibercept Biosimilars

Figure 63. Industry Chain Structure of Aflibercept Biosimilars

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles